SORL1 and hematopoietic and lymphoid cell neoplasm: Results with the Haferlach data set (Haferlach et al., 2010) are shown in Fig. 2D and suggest SORL1 is expressed at lower levels in CLL cells than normal PBMCs as well as other hematologic cancers such as acute lymphoblastic and myeloid leukemia, chronic myeloid leukemia, and myelodysplastic syndrome (Fig. 2D).